ABBV - AbbVie Inc.

NYSE - Nasdaq Real-time price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
58,054,000
58,054,000
56,197,000
45,804,000
33,266,000
Cost of revenue
17,414,000
17,414,000
17,446,000
15,387,000
7,439,000
Gross profit
40,640,000
40,640,000
38,751,000
30,417,000
25,827,000
Operating expenses
Research development
6,510,000
6,510,000
7,084,000
6,557,000
6,407,000
Selling general and administrative
15,260,000
15,260,000
12,349,000
11,299,000
6,942,000
Total operating expenses
21,826,000
21,826,000
19,865,000
17,856,000
12,459,000
Operating income or loss
18,814,000
18,814,000
18,886,000
12,561,000
13,368,000
Interest expense
2,230,000
2,230,000
2,384,000
2,280,000
1,509,000
Total other income/expenses net
-3,293,000
-3,293,000
-3,513,000
-6,883,000
-3,433,000
Income before tax
13,477,000
13,477,000
12,989,000
3,398,000
8,426,000
Income tax expense
1,632,000
1,632,000
1,440,000
-1,224,000
544,000
Income from continuing operations
11,845,000
11,845,000
11,549,000
4,622,000
7,882,000
Net income
11,836,000
11,836,000
11,542,000
4,616,000
7,882,000
Net income available to common shareholders
11,782,000
11,836,000
11,542,000
4,616,000
7,882,000
Basic EPS
-
6.65
6.48
2.73
5.30
Diluted EPS
-
6.63
6.45
2.72
5.28
Basic average shares
-
1,771,000
1,770,000
1,667,000
1,481,000
Diluted average shares
-
1,778,000
1,777,000
1,673,000
1,484,000
EBITDA
-
18,814,000
15,373,000
5,678,000
13,368,000